Skip to main content
Clinical Trials/ISRCTN13533177
ISRCTN13533177Active, not recruitingUnknown

Double-blind randomised controlled trial for treatment of Gastro-Oesophageal reflux disease; LINX management system vs Fundoplication (GOLF)

niversity of Oxford0 sites460 target enrollmentStarted: June 3, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Enrollment
460

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age 18 years and above
  • 2. Willing and able to give informed consent
  • 3. Patients with GORD insufficiently controlled by medical therapy or intolerance to medical therapy being considered for anti-reflux surgery
  • 4. Symptomatic and objectively defined GORD; endoscopy with appearances or biopsies consistent with reflux oesophagitis, or 24-hour pH study or BRAVO test of the oesophagus consistent with GORD
  • 5. No hiatal hernia or hiatal hernia <5 cm in length
  • 6. Adequate lower oesophageal motility as defined by preoperative oesophageal manometry study. Oesophageal manometry will show a mean contractile amplitude of >30 mmHg or DCI >450 mmHg-s-cm in 70% of swallows.

Exclusion Criteria

  • 1. Unsuitable for surgical intervention due to medical conditions precluding general anaesthesia
  • 2. Suspected or known allergies to titanium, stainless steel, nickel, or ferrous materials
  • 3. Previous anti-reflux or gastric surgery
  • 4. Previous or planned neurosurgical intervention
  • 5. Oesophageal manometry showing complete absence of lower oesophageal contractility

Investigators

Similar Trials